iSpecimen Inc.

ISPC ·Healthcare, Diagnostics & Research, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-1.4M $-2.3M $-5.0M $-2.8M $-1.0M $-1.7M $-6.0M $-1.4M
Depreciation & Amortization $201.5K $135.9K $407.7K $457.7K $432.7K $432.7K $548.0K $542.8K
Depreciation $2.1K $2.4K $17.1K $17.1K $17.1K $17.1K $17.1K $16.5K
Amortization — — $47.9K $47.9K $47.9K $47.9K $47.9K $47.9K
Stock-Based Compensation $153 $1.0K $1.8K $1.8K $1.8K $15.9K $11.0K $65.1K
Net Cash from Operating Activities $-689.6K $-3.4M $-916.9K $-2.0M $-192.2K $-1.1M $-3.6M $-1.1M
Investing Activities
Capital Expenditures — — — — — — $7.9K $14.5K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $0 $-700.0K — — — — $-73.1K $-180.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — $0
Net Cash from Financing Activities — — — — — — $3.8M $860.0K
Net Change in Cash — — — — — — — —
Free Cash Flow — — — — — — $-3.6M $-1.1M
← Newer Page 1 of 3 Older →